The latest closing stock price for EYEPOINT PHARMACEUTICALS, INC as of November 20, 2024 is 8.96.
An investor who bought $1,000 worth of EYEPOINT PHARMACEUTICALS, INC stock at the IPO in 2018 would have $-221 today, roughly 0 times their original investment - a -3.51% compound annual growth rate over 7 years.
The all-time high EYEPOINT PHARMACEUTICALS, INC stock closing price was 37.70 on October 03, 2018.
The EYEPOINT PHARMACEUTICALS, INC 52-week high stock price is 30.99, which is 245.9% above the current share price.
The EYEPOINT PHARMACEUTICALS, INC 52-week low stock price is 5.87, which is 34.5% below the current share price.
The average EYEPOINT PHARMACEUTICALS, INC stock price for the last 52 weeks is 15.03.
An investor who bought $1,000 worth of EYEPOINT PHARMACEUTICALS, INC stock at the IPO in 2018 would have $-221 today, roughly 0 times their original investment - a -3.51% compound annual growth rate over 7 years.
The all-time high EYEPOINT PHARMACEUTICALS, INC stock closing price was 37.70 on October 03, 2018.
The EYEPOINT PHARMACEUTICALS, INC 52-week high stock price is 30.99, which is 245.9% above the current share price.
The EYEPOINT PHARMACEUTICALS, INC 52-week low stock price is 5.87, which is 34.5% below the current share price.
The average EYEPOINT PHARMACEUTICALS, INC stock price for the last 52 weeks is 15.03.